Skip to main content
. 2024 Jul 6;16:154. doi: 10.1186/s13195-024-01521-9

Table 1.

Demographics and clinical characteristics

Characteristic Overall,
N = 1001
Butler MAP Training Cohort,
N = 501
Butler MAP Test Cohort,
N = 501
P-value2
Age 71 (64, 75) 69 (65, 75) 71 (64, 75) 0.96
Sex, male 46 (46%) 20 (40%) 26 (52%) 0.32
Race 0.28
White 77 (97%) 44 (100%) 33 (94%)
Black 1 (1.3%) 0 (0%) 1 (2.9%)
Mixed race 1 (1.3%) 0 (0%) 1 (2.9%)
Not reported 21 6 15
Ethnicity  > 0.99
Not Hispanic or Latino 74 (97%) 42 (98%) 32 (97%)
Hispanic or Latino 2 (2.6%) 1 (2.3%) 1 (3.0%)
Not reported 24 7 17
APOE-ε43 0.86
Non-carrier 25 (28%) 11 (27%) 14 (30%)
Heterozygote 51 (58%) 25 (61%) 26 (55%)
Homozygote 12 (14%) 5 (12%) 7 (15%)
Unknown 12 9 3
Clinical diagnosis  < 0.001
Cognitively normal 37 (37%) 37 (74%) 0 (0%)
Mild cognitive impairment 36 (36%) 7 (14%) 29 (58%)
Dementia 27 (27%) 6 (12%) 21 (42%)
 MMSE, score 27 (25, 29) 28 (26, 29) 27 (24, 28) 0.013
 MoCA, score 23 (19, 25) 25 (22, 27) 22 (18, 23)  < 0.001
 Aβ positivity 70 (70%) 32 (64%) 38 (76%) 0.28

1 Median (IQR); n (%)

2 Wilcoxon rank sum test; Pearson's Chi-squared test